# OnCo record paper-kras-nsclc-cancer-discov-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-kras-nsclc-cancer-discov-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-kras-nsclc-cancer-discov-2018" ;
  schema:name "STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma"@en ;
  schema:description "Phase 2 or 3 results paper on KRAS in Non-small-cell lung cancer, in Cancer Discovery (2018), one of the most cited Europe PMC records with KRAS in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-kras-nsclc-cancer-discov-2018/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/2159-8290.cd-18-0099>, <https://pubmed.ncbi.nlm.nih.gov/29773717/>, <https://europepmc.org/article/MED/29773717> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1158/2159-8290.cd-18-0099> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Skoulidis F, Goldberg ME, Greenawalt DM, et al." ;
  onco:related <https://onco.cc/biomarkers/stk11-keap1-loss/>, <https://onco.cc/biomarkers/kras-g12c/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cgp/> ;
  onco:targets <https://onco.cc/targets/stk11/>, <https://onco.cc/targets/kras/>, <https://onco.cc/targets/keap1/>, <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/pd1/> ;
  onco:pathways <https://onco.cc/pathways/t-cell-exhaustion/>, <https://onco.cc/pathways/ras-mapk/>, <https://onco.cc/pathways/pd1-checkpoint/> ;
  onco:terms <https://onco.cc/terms/stk11-keap1/>, <https://onco.cc/terms/cold-vs-hot/> ;
  onco:journals <https://onco.cc/journals/cancer-discovery/> .